Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03784170 · ClinicalTrials.gov registry record · NA
FemPulse Therapy for Overactive Bladder in Women
A NA study, sponsored by FemPulse Corporation.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT03784170 is a NA study that has completed, run by FemPulse Corporation. The registered enrollment target is 21 participants.
The verdict
NCT03784170, a NA study, has completed, sponsored by FemPulse Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
Interventions
- DEVICE FemPulse System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03784170
The ClinicalTrials.gov registry entry for NCT03784170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is FemPulse Corporation, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FemPulse System is the first listed.
NCT03784170 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03784170 about?
NCT03784170 is a clinical study titled "FemPulse Therapy for Overactive Bladder in Women". The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.
What is the current status of trial NCT03784170?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2018-12-11. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03784170?
The interventions under investigation include: FemPulse System (DEVICE).
Who is sponsoring clinical trial NCT03784170?
This trial is sponsored by FemPulse Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.